Caplin Point Laboratories Ltd shares closed at Rs 950.60 a share, up 1.28 percent on August 4, at a 52-week high of Rs 978.80 and a market capitalization of Rs 7,217 crores.
According to BSE data, the stock has delivered multibagger returns of about 72,723 percent over a 14-year period, spanning from Rs 1.30 in September 2009 to current stock price levels. It indicates that if a person had invested Rs 1 lakh in the stock, it would have gained to about Rs 7.28 crores after fourteen years.
Caplin Point Laboratories Ltd is engaged in the manufacturing of a wide range of Ointments, Creams and other External applications as well as sourcing of APIs, R&D, clinical research with presence in Latin America, Africa, USA and other nations.
Company’s Revenue grew by 15 percent from Rs 1,269 crore in FY 21-22 to Rs 1,466 crore in FY 22-23. During the same period, net profit climbed by 22 percent from Rs 308 crore to Rs 376 crore.
Over the years, the company has maintained outstanding financial metrics, with a return on equity of 20 percent and a return on capital employed of 23.50 percent. While the net profit margin is 25.69 percent and the operating margin is 30.82 percent.
In the previous six months, the stock has increased by 36 percent, and in the last year, it has increased by 15 percent.
As per latest shareholding pattern,The promoters held 70.63 percent stake of the company,foreign institutional investors own 2.68 percent and retail institutional investors owned 26.44 percent stake.
Written by Omkar Chitnis
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
